Stock Chart

IDYA

$32.40 +2.05%
Score: 49.6 HOLD
Pro
Screener
Vol: 0.24x (vs SPY: 0.7x | vs QQQ: 0.5x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 11, 2026
Falling Channel Bullish scenario quality 64/100
Measured-move target $35.85 (+12.0%)
Historically breaks up 64% of the time; target hit in 60% of up-breaks (n=559)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About IDYA - IDEAYA Biosciences, Inc. Common Stock

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). …

Key Statistics

Market Cap $3B

This IDYA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track IDYA's price movements with trendlines, gamma walls, and key support/resistance levels.